Despite the recent progress in identifying such pathogenic targets of RNF213, the identity of human substrates targeted for ubiquitination by RNF213 remains extremely limited [20,21], thus hampering progress in clarifying its direct in vivo functions and signal control mechanisms and its role in vasculopathies such as MMD. This evidence concerns the gene RNF213 and vascular disorder.